RxSight
RXST
151 hedge funds and large institutions have $200M invested in RxSight in 2026 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 72 increasing their positions, 35 reducing their positions, and 36 closing their positions.
106% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 35
7.54% more ownership
Funds ownership: 92.56% → 100.09% (+7.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less funds holding
Funds holding: 164 → 151 (-13)
15% less capital invested
Capital invested by funds: $235M → $200M (-$35.4M)
31% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 36
59% less call options, than puts
Call options by funds: $96K | Put options by funds: $233K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$15.7M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$5.93M |
| 3 |
Millennium Management
New York
|
+$5.86M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$5.42M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$12.7M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$4.37M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$4.25M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.55M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.52M |
RXST Hedge Fund Activity: Q2 2026 in Review
151 of the 8,316 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q2 2026, worth a combined $200M — down 15% from $235M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of RXST and 25 opened new positions — a net loss of 11 holders — while 35 trimmed existing stakes and 72 added.
The largest buyer was BlackRock, adding an estimated $15.7M. The largest seller was Artisan Partners, exiting entirely with an estimated $12.7M sold.
- 151 institutional investors held RxSight (RXST) as of Q2 2026, down from 164 in Q1 2026.
- Funds reported $200M of RxSight stock for Q2 2026, down 15% quarter-over-quarter.
- 25 funds opened new RxSight positions in Q2 2026 and 36 closed out, a net change of -11 holders.
- The largest RxSight buyer in Q2 2026 was BlackRock, an estimated $15.7M added.
- The largest RxSight seller in Q2 2026 was Artisan Partners, an estimated $12.7M sold.
Based on aggregated 13F filings for Q2 2026.